Notal Vision
Beni C. is an experienced engineering professional with a strong background in production engineering and product management. Currently serving as Production Engineering Manager at Notal Vision since July 2023, Beni leads the implementation and management of the Product Data Management system while collaborating with cross-functional teams. Previous roles include Product Engineer at NovaSight, focusing on the transition from R&D to production, and New Product Introduction Engineer at EPS Technology, where Beni specialized in configuration control and manufacturing support. Beni's earlier experience includes positions at Orbit Communications Systems as a Senior NPI Engineer, Corning Incorporated in both verification and validation testing and product leadership, and several engineering roles at Minicom, Kinetics LTD., TeraChip, BigBand Networks, and Avaya. Beni holds a Bachelor's degree in Electrical and Electronics Engineering from Tel Aviv University.
This person is not in any offices
Notal Vision
Notal Vision is a patient-centric ophthalmic remote monitoring services provider extending retinal disease monitoring from the clinic to the home, providing physicians with remote monitoring services to support their patient care between office visits. With a proven approach to home-based, self-operated diagnostics, AI-enabled data analysis, and patient engagement, we help preserve patients’ vision. The Notal Vision Monitoring Center is a remote, Medicare credentialed ophthalmic provider and the epicenter of patient engagement. Led by practicing ophthalmologists and supported by certified ophthalmic professionals, the Monitoring Center offers a comprehensive nationwide age-related macular degeneration (AMD) home monitoring service for referred patients. The ForeseeHome® AMD Monitoring Program helps physicians detect the conversion to wet AMD early, leading to earlier treatment intervention and better visual outcomes. Our Home OCT pipeline technology will provide patient-initiated retinal OCT scans to support the management of patients with neovascular retinal diseases, complementing existing in-office imaging and standard of care treatments as well as emerging longer acting drugs and drug delivery systems.